Articles by Laura Litwin
The researchers discussed details from their ONS Congress 2025 presentation on fueling the oncology nurse scientist pipeline.
Tobacco smoking accounts for 50-65% of bladder cancer cases in men and 20-30% of cases in women.
The researchers discuss their study on palliative treatment disparities in disaggregated Hispanic patient populations.
Josie Montegaard, NP, shares insights on how nurses can help patients manage their mental health during CLL treatment.
Josie Montegaard, NP, discusses key developments in the field of CLL and how they will innovate the treatment landscape.
MD Candidate Komal Hombal discusses her research on patient anxiety before and after gynecologic oncology consultations.
Researchers highlighted that patients with poor access to transportation are at risk of protracted or incomplete treatment.
The researchers explored the effect and acceptance of scalp cooling in patients with gynecologic cancer residing in Asia.
Data on clinical features and outcomes in the Hispanic and Latino communities with metastatic RCC are limited.
Dr. Di Meglio discussed his research on trajectories of multidimensional worry in patients with early-stage breast cancer.
The investigators conducted semistructured phone interviews to recruit patients with bladder, prostate, or kidney cancer.
Garg explained the importance of investigating disparities across racial and ethnic groups in the Hispanic community.
Uterine carcinosarcoma is responsible for more than 16% of all deaths caused by uterine malignancy, despite its rarity.
Uterine cancer, including endometrial carcinoma, is a major public health concern in the EU.
The findings were presented as an abstract during the American Society of Clinical Oncology 2025 Annual Meeting.
Dr. Loibl discusses the importance of involving nurses in breast cancer treatment to mitigate medication side effects.
Chronic GVHD can increase the risk of infections, graft failure, and multi-organ dysfunction in patients.
The open-label phase 2 clinical trial enrolled 33 patients with resectable, high-risk ccRCC.
Optimal management of non-clear cell renal cell carcinoma remains an unmet need.
Dr. Darabos highlighted that a lack of social support in patients with cancer is associated with adverse health outcomes.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.